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ABSTRACT The polypeptide composition of epidermal keratin varies in disease. To better
understand the biological meaning of these variations, we have analyzed keratins from a
number of human epidermal diseases by the immunoblot technique using AE1 and AE3
monoclonal antikeratin antibodies . The results reveal a continuous spectrum of keratin
expression ranging from one closely resembling the normal in vivo pattern to one almost
identical to cultured epidermal keratinocytes. Specifically, a 50-kilodalton (kd) (AEl-positive)
and a 58-kd (AE3-positive) keratin are present in all diseases, supporting the concept that they
represent "permanent" markers for keratinocytes. A 56.5-kd (AE1) and a 65-67-kd (AE3)
keratin, previously shown to be markers for keratinization, are expressed only by lesions
retaining a keratinized morphology. A 48-kd (AE1) and a 56-kd (AE3) keratin are present in all
hyperproliferative (para- or nonkeratinized) disorders, but not in normal abdominal epidermis
or in ichthyosis vulgaris which is a nonhyperproliferative disease . These two keratins have
previously been found in various nonepidermal keratinocytes undergoing hyperproliferation,
suggesting that these keratins are not epidermis-specific and may represent markers for
hyperproliferative keratinocytes in general . In various epidermal diseases, there is a reciprocal
expression of the (keratin) markers for hyperproliferation and keratinization, supporting the
mutual exclusiveness of the two cellular events. Moreover, our results indicate that, as far as
keratin expression is concerned, cultured human epidermal cells resemble and thus may be
regarded as a model for epidermal hyperplasia. Finally, the apparent lack of any major, disease-
specific keratin changes in the epidermal disorders studied so far implies that keratin abnor-
malities probably represent the consequence, rather than the cause, of these diseases.
The keratins are a group of water-insoluble proteins (40-70
Kdaltons [kd])' that form 10-nm desmosome-associated ton-
ofilaments in all epithelia (15, 17, 18, 61, 63, 64). Four major
keratins (50, 56.5, 58, and 65-67 kd) have been identified in
normal human epidermis (7, 21, 40, 72; cf. 4, 49, 62); signifi-
cant alterations in epidermal keratin composition can occur,
however, as a result of disease (1, 3, 5, 25, 26, 28, 33, 34, 36,
37, 40, 50, 52, 54, 66, 71) as well as changes in cellular growth
environment (10, 20, 29, 55, 61, 62).
Numerous attempts have been made to characterize such
'Abbreviations used in this paper:
￿
BCC, basal cell carcinoma; IEF,
isoelectric focusing; kd, kilodaltons.
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keratin variations in epidermal diseases. Recent studies have
demonstrated that some, but not all, psoriatic epidermal
specimens possess a reduced level of 65-67-kd keratins (1, 5,
8, 37, 50, 54, 66). In addition, Thaler et al. (65, 66) reported
that two water-insoluble proteins of -54 and 57 kd are unique
to psoriatic scale, although Baden et al. (5) found no "pso-
riasis-specific" keratin changes. Hunter and Skerrow (26)
reported that certain abnormal keratin polypeptides ranging
from 55-63 kd (probably corresponding to 50-58 kd in our
gel system) are present in the scales of psoriasis, atopic der-
matitis, and seborrheic dermatitis, as well as in the stratum
comeum oftape-stripped epidermis. Interestingly, Kubilus et
al. (28) found that keratins of another disease, basal cell
1397carcinoma (BCC), are similar to those synthesized by cultured
normal human keratinocytes. Moll et al. (40) further dem-
onstrated that BCC expresses a 46-kd keratin that is present
in cells of the pilosebaceous unit but absent in interfollicular
epidermis. Finally, Steinert et al. (54) analyzed keratins iso-
lated from several epidermal disorders including psoriasis,
lamellar ichthyosis, and Darier's disease. They found variable
amounts of small molecular weight components (<50 kd) in
all specimens, presumably due to an elevated level ofprotease
activity in diseases. These results firmly established that ker-
atin expression can be affected by various disease states.
However, since results from different laboratories have not
always been consistent with one another, the significance of
such findings is unclear, and the existence of disease-specific
keratins remains controversial.
We have previously described the preparation and charac-
terizationofseveral mouse monoclonal antikeratin antibodies
(72). Two of these antibodies, designated AEI and AE3,
recognize two mutually exclusive subfamilies of keratins.
Keratins of the AEl (or A) subfamily are relatively acidic,
whereas those of the AE3 (or B) subfamily are relatively basic
(12). In combination, the two antibodies recognize most
known keratin species (12, 57, 58, 68, 72) and therefore
provide an excellent tool for studyingepithelialkeratin expres-
sion.
In the presence of lethally irradiated 3T3 feeder cells, hu-
man epidermal keratinocytes form stratified colonies and
undergo terminal differentiation (47). However, unlike the
normal epidermis which is keratinized, cultured cells fail to
form the granular layer and enucleated cornified layers and
therefore may be described as "nonkeratinized" (31, 47).
Using monoclonal antikeratin antibodies, we have recently
demonstrated that a 50-kd keratin (recognized by AEI anti-
body) and a 58-kd keratin (AE3) are expressed by epidermal
cells, both in vivo and in culture (12; also see 21). In addition
to these two keratins, in vivo epidermis expresses a 56.5-
(AEI) and a 65-67-kd keratin (AE3), which are made only
during advanced stages of epidermal differentiation (59, 72;
cf. 21, 51) and thus may be regarded as molecular markers
for keratinization (59, 68, 72). Instead of synthesizing these
"keratinization markers," cultured epidermal cells are char-
acterized by a 48- (AEI), a 56-kd (AE3), and several other
keratins not detectable in normal epidermis (12, 21, 62). The
significance of these "culture-type" keratins remains unclear.
We demonstrate in this paper that the 48- and 56-kd
"culture-type" keratins are present not only in various cul-
tured keratinocytes (12, 62, 73), but also in all hyperprolifer-
ative epidermal diseases examined so far. Such results suggest
that these two keratins may be regarded as markers for
hyperproliferative keratinocytes.
MATERIALS AND METHODS
Monoclonal Antibodies:
￿
The preparation and charcterization of
AE 1, AE2, and AE3monoclonal antikerafin antibodies have been described in
detail previously (68, 72).
Patient Selection:
￿
Specimens ofepidermal diseases were obtained by
4-mm punch biopsy, excisional biopsy, shave biopsy, or curettage in the out-
patient dermatology clinic at the Johns Hopkins Hospital. The total number
of epidermal disease samples studied were as follows: psoriasis (10 cases),
ichthyosis vulgaris (1), contact dermatitis (2), atopic dermatitis (2), dermato-
myositis (2), keratoacanthoma (2), actinic keratosis (2), verruca vulgaris (wart)
(2), verrucous carcinoma (1), Bowen's disease (1), squamous cell carcinoma
(3), and basal cell carcinoma (4). A portion of the samples was fixed in
formaldehyde for routine histology (hematoxylin and eosin staining); the re-
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maining tissue was flash-frozen in liquid nitrogen and stored at -70'C prior to
protein extraction. Keratins isolated from normal human abdominal, breast,
and back skin as well as neonatal foreskin (exterior, nonmucosal portion) were
used as controls, with similar results.
Keratin Extraction:
￿
Instead of using comified cells (also called scales
or stratum corneum) whose keratins are partially degraded (7, 21, 53, 72), we
isolated keratins from intact epidermis predominantly represented by living
layers. The epidermal portions of various diseases, normal skin, or cultured
human keratinocyteswere mincedandhomogenizedat4°C in --50-100 volume
(vol/wt) of 25 mM Tris HCl (pH 7.4) containing the following protease
inhibitors: I mM phenylmethylsulfonyl fluoride (PMSF), antipain (10 kg/ml,
Sigma Chemical Co., St. Louis, MO), pepstatin (5 Ag/ml, Sigma Chemical Co.),
1 mM EDTA, and I mM EGTA. After centrifugation (10,000 for 10 min at
4°C), the keratin-containing pellet was recovered andheated at 95°C for 5 min
in a solution containing 25 mM Tris HCI (pH 7.4), 5% 2-mercaptoethanol,
and1-5% SDS. For two-dimensional gel electrophoresis, aportion ofthewater-
insoluble pellet was extracted at room temperature for 15 min with a buffer
containing9.5 M urea, 50 mM dithiothreitol, and 25 mM Tris HClbuffer (pH
7.4) (72).
Gel Electrophoresis and lmmunoblot Analysis:
￿
One-dimen-
sional (Laemmli-type) SDS-polyacrylamide gel electrophoresis (SDS PAGE;
12.5% acrylamide) was performed as previously described (62). Equilibirum
andnonequilibrium two-dimensional gel electrophoresis were done according
to O'Farrell et al. (44, 45). One- and two-dimensional immunoblot analyses
using the peroxidase-antiperoxidase technique were done as described earlier
(12, 67, 72).
Cell Culture:
￿
Secondary cultures ofnewborn human foreskin-derived
epidermal cells were grown in the presence of lethally irradiated (4,000 Rads)
3T3 feeder cells (47). Keratins were extracted from both sparse (exponentially
growing) and confluent cultures, with similar results.
RESULTS
A 48- and a 56-kd Keratin Were Present in a
Wide Variety of Epidermal Diseases
To determine the possible corrrelation between the expres-
sion of specific keratins and certain abnormal features of
epidermal differentiation, we have analyzed keratins isolated
from various human epidermal diseases. Ichthyosis vulgaris,
which is characterized by a decreased granular layer, was used
as an example ofa nonhyperproliferative epidermal disorder.
Benign hyperproliferative diseases studied include psoriasis (a
common disease of unknown etiology), verruca vulgaris (hu-
man papilloma virus-induced hyperproliferation; also known
as common wart), actinic keratosis (solar damage-induced
hyperproliferation), and keratoacanthoma (a rapidly growing,
benign tumor which resembles squamous cell carcinoma).
The malignant hyperproliferative diseases studied include
basal cell carcinoma,squamouscell carcinoma,and verrucous
carcinoma (a verruca-like squamous cell carcinoma). Other
epidermal disorders studied include a variety of dermatitis in
which the epidermis is believed to be in a hyperproliferative
state when regenerating; these included atopic dermatitis,
contact dermatitis, and dermatomyositis. Keratins of these
epidermal disorders were compared with those isolated from
normal epidermis and cultured newborn foreskin epidermal
cells.
Water-insoluble cytoskeletal proteins were extracted from
various epidermal specimens in the presence of a mixture of
protease inhibitors (see Materials and Methods) and analyzed
by SDS PAGE. Protein staining revealed several interesting
points (Fig. 1 a). First, the 50- and 58-kd keratins, which are
expressed by both normal epidermis and cultured keratino-
cytes (12, 21), were present in all epidermal diseases. Second,
the 65-67 kd keratin, a marker for phenotypic keratinization
(58, 59, 68, 72; cf. 10, 22, 39), was diminished in many
diseases, perhaps reflecting a decreased degree of morpholog-
ical keratinization. A complete loss of this keratin was rou-FIGURE 1
￿
Immunoblot analysis of keratins isolated from various epidermal diseases. (a) Fast green (FG) staining : lane 1, keratins
of normal abdominal skin ; lane 2, ichthyosis vulgaris; lane 3, atopic dermatitis (bar and arrowhead designate the 48- and 46-kd
keratins, respectively, which are only partially resolved by 1-D gels) ; lanes 4 and 5, two different cases of psoriasis showing
different amounts of 65-67 kd keratins ; lane 6, keratoacanthoma ; lane 7, actinic keratosis; lane 8, wart; lane 9, verrucous
carcinoma ; lanes 10 and 11, two different cases of squamous cell carcinoma showing slightly different keratin patterns; lane 12,
basal cell carcinoma ; lane 13, cultured normal human epidermal keratinocytes . Note the striking similarity between the overall
keratin pattern of some diseases and that of cultured epidermal cells . The sharpness of keratin bands suggests that the great
majority of the keratins must have originated from epidermal living layers (72) (b) Immunoblot staining of the same samples using
AEI monoclonal antibody which selectively reacts with keratins of subfamilyA (see reference 12) . Note the detection of a 48-kd
keratin (bar) in all hyperproliferative diseases . Also note the decreased amounts of 56.5-kd keratin in many hyperproliferative
diseases, the ubiquitous presence of 50-kd keratin in all specimens, and the absence of 40-kd keratin in diseases . The small
molecular weight (<48 kd) AEI-reactive components in lanes 4, 6, 7, and 9 may represent degradative products . (c) Immunoblot
staining of the same samples using AE3 monoclonal antibody which selectively recognizes keratins of subfamily B (12) . Note the
detection of a 56-kd keratin in all hyperproliferative diseases . Also note the presence of a 58-kd keratin in all samples, and the
decreases in the 65-67-kd keratins in many diseases (cf. gel b) . The small molecular weight, AE3-reactive species (<56 kd) in
lanes 4, 6, 7, and 9 are presumably proteolytic degradative products (cf . Fig . 1 b) . Values represent keratin molecular weight
x 10-3 .
tinely observed in "undifferentiated" basal cell carcinomas
(Fig. 1, lane 12; [28, 39, 40]), consistent with their nonkera-
tinized morphology . Third, a 46/48-kd doublet and a 56-kd
band, similar to those of cultured keratinocytes, were detected
in most diseases except in nonhyperproliferative ichthyosis
vulgaris. Finally, there appeared to be a spectrum of keratin
expression ranging from an almost normal in vivo pattern
(ichthyosis vulgaris) to that of cultured epidermal keratino-
cytes (e.g ., basal cell carcinomas, squamous cell carcinomas,
and some specimens of benign diseases ; Fig. 1 a, lanes 7-12 ;
also see below) . The keratin patterns ofmany specimens were
intermediate between these two extremes and represented a
combination, with various proportions, of the in vivo and in
vitro keratin components .
To further characterize these keratins, we analyzed them
by the immunoblot technique using AE 1 and AE3 mono-
clonal antikeratin antibodies (72) . Consistent with our earlier
results (12, 72), AE1 recognized in normal epidermis a 56.5-
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1399kd keratin (a keratinization marker) and a 50-kd keratin (a
marker for stratifiedepithelia; Fig. 1 b, lane 1); and in cultured
cells a 50-, a 48-, and a 40-kd keratin (Fig. 1 b, lane 13).
Immunoblot analysis of abnormal epidermal tissues (Fig. 16)
showed that the 50-kd keratin was ubiquitous and that the
56.5-kd keratin was diminished in many diseases. Also, as
shown earlier (12), AEI reacted strongly with the 48-kd but
not the 46-kd component of the 46/48-kd doublet ofcultured
keratinocytes. This AEI-reactive 48-kd keratin was clearly
demonstrated in all diseases that are hyperproliferative, but
not in normal abdominal epidermis or nonhyperproliferative
ichthyosis vulgaris (Fig. 16). A few low molecular weight
AEI-reactive species were occasionally detected which prob-
ably represented proteolytic fragments ofkeratins (54), despite
the inclusion of several protease inhibitors in our extraction
buffers. Finally, no well-defined 40-kd keratin was detected
in any of the epidermal diseases, neoplasms included (Fig.
16).
The results obtained by AE3 staining (Fig. 1 c) were strik-
ingly parallel to those of AEI staining. In normal human
epidermis, AE3 recognized the 65-67-kd keratin (a keratini-
zation marker) that, like the AEI-reactive 56.5-kd keratin,
was present in diminished amounts in many diseases. The 58-
kd keratin (a marker for stratified epithelia), like the AE1-
reactive 50-kd keratin, was common to normal epidermis,
cultured cells, and all diseases. In addition, AE3 antibody
staining demonstrated that the 56-kd keratin, like the AEI-
reactive 48-kd keratin, was present in almost all hyperprolif-
erative diseases as well as cultured keratinocytes, but not in
normal abdominal epidermis or ichthyosis vulgaris (Fig. 1 c).
Expression of Both "In Vivo" and "Culture" Types
of Epidermal Keratins in Diseases
To better characterize the keratins of various diseases,
we analyzed them by two-dimensional polyacrylamide gel
electrophoresis in which the proteins were first resolved by
isoelectric focusing (IEF) or nonequilibrium pH gradient
(NEpHG) electrophoresis followed by SDS gel electrophoresis.
After being transferred to nitrocellulose paper, the proteins
were visualized by Fast green staining. Fig. 2, a-c show the
IEF-SDS gel patterns ofthe keratins ofnormal epidermis (Fig.
2 a), cultured keratinocytes (Fig. 2 b), and psoriasis (Fig. 2c);
Fig. 2, a'-c' show the immunoblotresults of the correspond-
ing gels with AE 1 antibody. As shown earlier, keratins of the
AE 1 (or A) subfamily are relatively acidic (12) and are well
resolved in this gel system (62, 72). The results indicated the
following: first, a 50-kd keratin and a more acidic "50'-kd"
variant were present in all specimens; second, the 56.5-kd
keratin (and its 55-56 kd, AEI-positive, degradative product,
[72]) was present in normal epidermis and psoriasis, but not
in cultured keratinocytes; and, third, the 48-kd keratin was
present in psoriasis and cultured keratinocytes, but not in
normal abdominal epidermis. These results indicated that,
within the AEI keratin subfamily, psoriatic epidermis could
express both in vivo and culture keratin types (except for the
40-kd keratin, see below).
Two-dimensional gel electrophoresis in which the first di-
mensional separation was done under nonequilibrium con-
ditions allowed the simultaneous resolution of both acidic
and basic epidermal keratins (instead of only the more acidic
AEI-reactive keratins by IEF; [16, 40, 74]). The results were
entirely consistent with those obtained by one-dimensional
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SDS gels and two-dimensional IEF-SDS gels and provided
further evidence that an acidic, AEI-reactive 48-kd keratin
(Fig. 3 and data not shown) and a basic, AE3-reactive 56-kd
keratin (Fig. 3 and data not shown), that were absent in
normal abdominal epidermis (Fig. 3 a) and ichthyosis vulgaris
(Fig. 3 c), were common to cultured keratinocytes (Fig. 3b)
and a wide variety of hyperproliferative diseases including
psoriasis (Fig. 3 d), wart (Fig. 3 e), and basal cell carcinoma
(Fig. 3j).
A Spectrum of Keratin Expression in a Single
Disease (Psoriasis): Morphological Correlations
In the experiments described above, each disease was
treated as a separate entity. Previous results have indicated,
however, that variations in keratin expression may exist even
within a given disorder (3-5, 8, 34, 50, 54, 66). To determine
the possible relationship between the expression of the 48-
and 56-kd keratins and specific morphological features within
a disease, we studied keratin expression in 10 cases of pso-
riasis. Analysis of their keratins by SDS PAGE (Fig. 4a) and
immunoblot technique (Fig. 1 and data not shown) revealed
a spectrum ofkeratin expression. The keratin patterns varied
from one closely resembling the normal in vivo pattern (Fig.
4a, lanes 2 and 3) to one almost indistinguishable from
cultured keratinocytes (Fig. 4a, lane 4). Histological exami-
nation (Fig. 46) showed that the disappearance of the 56.5
and 65-67-kd keratins and the appearance of the "culture
type" keratins correlated well with the degree of parakeratin-
ization (as defined by the lack of a granular layer and the
formation ofan abnormal, nucleated stratum corneum [32]).
These findings confirmed and extended earlier results by
Baden (5), Skerrow (25, 50), Thaler (66), and Bowden (8) and
their co-workers, and provided additional evidence that the
56.5- and the 65-67-kd keratins may serve as molecular
markers for morphological keratinization (68, 72). Our data
also suggested a strong correlation between the expression of
56- and 48-kd keratins and the degree of abnormal epidermal
growth and/or differentiation.
This continuousspectrum ofkeratin expression as observed
in psoriasis (Fig. 4) and other epidermal diseases (Fig. 1) is
schematically summarized in Fig. 5.
DISCUSSION
A 48- and a 56-kd Keratin as Molecular Markers
for Hyperproliferative Keratinocytes
In the present study, we have identified a 48- and a 56-kd
keratin in many epidermal disorders. Although elevated pro-
tease activities have been suggested for certain diseases (14,
54), it seems highly unlikely that these two polypeptides
represent degradative products of some higher molecular
weight keratin components, for the following reasons. First,
cultured epidermal cells expressed keratins that were identical
to the 48- and 56-kd components of the diseases according to
one- and two-dimensional gel electrophoretic mobilities, as
well as reactivities with monoclonal antikeratin antibodies
(Figs. 1-3). Cell-free translation experiments showed that, at
least in cultured cells, these keratins represent primary trans-
lational products encoded by separate mRNA's (19, 21).
Second, monoclonal antibody reactivitydata preclude certain
precursor-product relationships. For example, the 65-67-, 58-
or 56-kd keratins are unlikely to give rise to the 48-kd keratin,FIGURE 2
￿
Analysis of the acidic human epidermal keratins by two-dimensional gel electrophoresis (equilibrium; IEF-SIDS). a and
a', normal abdominal epidermis ; b and b', cultured human epidermal cells ; c and c', psoriasis . a-c were stained by Coomassie
Blue, whereas a'-c' were stained with AEI monoclonal antikeratin antibody by the peroxidase-antiperoxidase technique . Keratins
are identified by their molecular weights (see text for the nomenclature of Moll et al . [39)) . Arrows in a and a' denote the absence
of 48-kd keratin in normal epidermis . The brackets indicate the keratin complexes not resolved during isoelectric focusing but
dissociated during SIDS gel electrophoresis (40, 74) . Note that the psoriatic sample contains both "in vivo" and "culture type"
keratins (also see Fig . 3) . The 40-kd keratin, however, appears to be characteristic of cultured cells . In Fig. 2c', the minor AE1-
reactive spot below the 48-kd keratin was seen only in a few preparations and may represent a degradative product of the 48-kd
keratin . A comparison of Figs . 2 c and c'showed that AE1 reacted with the 48, 50, and 56.5-kd keratins with a decreasing order
of intensity . Experiments in which the same blot was visualized first with Fast green staining followed by AE1 reaction showed
that this variation in staining intensity was not due to a decreased transfer of larger proteins to the paper (see, e .g ., Fig. 1, a and
b) . Rather, this could be due to either a difference in the number of antigenic determinants per molecule or, perhaps more likely,
small differences in antigenic sites (12) .
1401FIGURE 3
￿
Analysis of total human epidermal keratins by two-dimensional gel electrophoresis (nonequilibrium; NEpHG-SDS) .
The basic proteins are to the left . a, normal abdominal epidermis ; b, cultured newborn foreskin epidermal cells ; c, ichthyosis
vulgaris ; d, psoriasis; e, wart ; f, basal cell carcinoma. Keratins are visualized after Coomassie Blue staining and are identified by
molecular weights . As in Fig . 2, horizontal brackets denote keratins that remain associated as a complex during the first
dimensional separation .
since the former are AEI-negative whereas the latter is AEI-
positive . Finally, the same amounts of these keratins were
detected both in the presence and absence ofvarious protease
inhibitors including PMSF, pepstatin, antipain, EDTA, and
402
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EGTA . Boiling the epidermal specimens directly in high
concentrations ofSDS plus reducing agent, one of the most
stringent conditions known to inhibit proteolytic activities,
also did not affect the level of these keratins .FIGURE 4
￿
A spectrum of keratin expression in psoriasis. (a) SIDS gel electrophoresis : water-insoluble cytoskeletal proteins were
electrophoresed and stained by Coomassie Blue . Lane 1, normal abdominal epidermis; lane 2, uninvolved skin adjacent to a
plaque lesion ; lane 3, a psoriatic lesion with a "keratinized" morphology (formation of granular and cornified layers) . As reported
earlier, nearly one-third of clinically typical lesions of psoriasis showed keratinization to be more prevalent than parakeratinization
(see page 142 of [321 ; also see below); lane 4, another case of psoriasis showing parakeratinization (formation of a nucleated
stratum corneum, which is frequently associated with a lack of underlying granular layer). Lane 5, cultured newborn foreskin
keratinocytes . Std, molecular weight standards that are, from top to bottom, bovine serum albumin (68 kd), catalase (60 kd),
fumarase (49 kd), ovalbumin (45 kd), aldolase (40 kd), and trypsinogen (24 kd) . a denotes residual actin . (b) Histology of the
corresponding specimens . Parts of the specimens analyzed (top) were fixed with formalin and processed for routine histology
(hematoxylin and eosin staining) . Note the parakeratinized morphology of psoriatic specimen no . 4, and the nonkeratinized
morphology (a total lack of stratum corneum) of the cross-section of a cultured epidermal colony (specimen no . 5) .
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FIGURE 5
￿
A schematic representation of the spectrum of keratin
expression in epidermal diseases. The keratin pattern of normal in
vivo epidermis is shown to the left, that of cultured keratinocytes
to the right, and those of various diseases studied so far in between .
The black bars denote the acidic 50 kd (AE1 ; subfamily A) and basic
58 kd (AE3; subfamily B) keratins which are always expressed
(constant members, [12]). The stippled bars denote the acidic 56.5-
kd (AE1; subfamily A) and basic 65-67-kd (AE3; subfamily B) keratins
which represent markers for phenotypic keratinization (68, 72). The
hatched bars denote the acidic 48-kd (AE1 ; subfamily A) and basic
56-kd (AE3; subfamily B) keratins which represent markers for
hyperproliferative keratinocytes. All the above-mentioned keratins
are keratinocyte-specific . The 40, 46, and 52-kd keratins are present
in cultured keratinocytes and some epidermal diseases; these ker-
atins are also found, however, in simple epithelia and therefore are
not keratinocyte-specific (open bars). (A) Keratins expressed by
normal trunk epidermis and ichthyosis vulgaris (Fig. 1). (B) Keratins
expressed in various hyperproliferative epidermal disorders. While
the 50- and 58-kd keratins are present throughout the spectrum,
the expression of the 65-67 and 56.5-kd keratins (markers for
keratinization) and 56, 52, 48, 46, and 40-kd keratins ("culture-
type") was variable and appeared to be related to the degrees of
keratinization vs. hyperproliferation . Many disease specimens pos-
sessed both "keratinization markers" and "culture-type keratins,"
most likely reflecting the heterogeneous expression of these two
types of keratins by individual keratinocytes. This explains the
apparent complexities in keratin pattern frequently seen in disor-
ders (Figs. 1-3; cf. [41]) . The entire spectrum of keratin expression
as shown in this diagram can sometimes be seen even within a
single disease, such as psoriasis (Fig. 4 and text). (C) The keratin
pattern of basal cell carcinoma was very similar to that of cultured
epidermal cells (28), except for the absence of40-kd keratin which
was detectable only in cultured cells (Figs. 1-3). (D) Keratinocytes
cultured under in vitro conditions in the presence of 3T3 feeder
cells (47) and various growth-stimulating factors, e.g., epidermal
growth factor, vitamin A, hydrocortisone, etc. (Figs. 1-4). By re-
moving these growth factors, the cells can be induced to keratinize
partially (12, 22). Values represent keratin molecular weight x 10'.
Thus we have established in many epidermal diseases the
existence of a 48-kd keratin (AEl-reactive; subfamily A,
[12]; pI 5.1 ; no. 16 of Moll et al. [39]) and a 56-kd keratin
(AE3 ; subfamily B; pl 7.8; no. 6). Independently, Osber and
McGuire (46) have also identified these two keratins in pso-
riatic epidermis. These two keratins are clearly not disease-
specific, however, since they are expressed not only in epider-
mal disorders with diverse etiology and pathogenesis (Figs. 1-
3), but also in normal heel epidermis (8, 21, 39, 40, 72), trunk
epidermis induced to hyperproliferate by tape-stripping (R.
A. Weiss and T.-T. Sun, unpublished results), and short-term
organ-cultured human epidermis (13, 46). An acidic, water-
insoluble protein (band 8) similar to our 48-kd keratin has
also been found in mouse epidermis during phorbol ester-
induced hyperplasia (48), although the significance of this
earlier finding was not discussed. Since epidermal cells in all
these diseases or conditions are known or thought to be
hyperproliferative (6, 9, 24, 32, 69), such results suggest that
the expression of the 48- and 56-kd keratins is related to
epidermal hyperproliferation, whether physiological (e.g., nor-
mal heel epidermis) or pathological (diseases and tape-
stripped epidermis).
Existing data also indicate that these two keratins are ex-
pressed in cultured human corneal, conjunctival, esophageal,
as well as skin epithelial cells (Figs. 1-4; 10, 21, 43, 61, 74).
In sparse cultures, these cells undergo exponential growth
with a doubling time of -24 h and thus are clearly hyperpro-
liferative (60). Although the precise turnover rate of these
cells in confluent cultures has not yet been established, recent
data on cell kinetics (11) and cell shedding (23, 30, 38) suggest
that these cellsare probably also hyperproliferative. Moreover,
recent data by Moll et al. (39, 41) and Nelson et al. (42)
showed that the 48- and 56-kd keratins are present in some
nonepidermal stratified epithelia normally exhibiting a high
turnover rate, as well as in almost all squamous cell carcino-
mas regardless of their tissue-origin. These findings indicate
that the 48- and 56-kd keratins are not epidermis-specific and
thus may be regarded as molecular markers for a hyperprolif-
erative state (or an associated, altered differentiated state) of
keratinocytes in general.
Expression of Other Keratins in
Epidermal Diseases
We have previously shown that the 56.5-kd (AE1-reactive;
subfamily A, [ 12]; pl 5.3; no. 10 of Moll et al. [39]) and the
65-67-kd keratins (AE3, subfamily B; pl 6-8; no. 1 and 2)
represent molecular markers for phenotypic keratinization
(12, 58, 59, 68, 72). Our present finding that in various
epidermal diseases the expression of these two keratins cor-
related well with the degree of morphological keratinization
(Fig. 4) provided further support for this concept.
Existing data indicate that the 50/50'-kd (AE 1 ; subfamily
A; pI 5-5.3; no. 14/15) and 58-kd (AE3; subfamily B; pI 7.4;
no. 5) keratins represent markers for stratified squamous
epithelia (43, 68; cf. 39). Results from the present work (Fig.
1) further established that these two keratins are always ex-
pressed (constant members; [12]) by epidermal cells under a
wide variety of conditions (normal tissue, cell culture, and
benign and malignant diseases).
A minor cytoskeletal protein of 52 kd (AE3; subfamily B;
pl 6.1 ; no. 8) was detected in cultured human keratinocytes
and occasionally in diseases. Under normal conditions this
protein is primarily expressed by simple epithelia (39, 68).
A 46-kd keratin (subfamily A; pl 5 .1 ; no. 17) was detected
in various quantities in diseases including BCC (28, 40). In
view of the structuralsimilarities among the 46-, 48-, and 50-
kd keratins (40), it is somewhat surprising that AE 1 antibody
selectively recognizes the two latter keratins, but not the 46-
kd component (12). Interestingly, the AEI-positive 48- and
50-kd keratins appear to be specific for stratified squamous
epithelial cells (39, 43, 68), whereas the AEI-negative 46-kd
keratin is expressed not only by keratinocytes, but also by
some simple epithelial cells (e.g., HeLa cells; [13, 39-43]).Although the 40-kd keratin (AE1; subfamily A; pl 5.2; no.
19) can be readily detected in cultured keratinocytes by AE1-
antibody staining, it was apparently not expressed to any
significant extent in any of the epidermal diseases including
neoplasms (Fig. 1; also see below). This suggests that the 40-
kd keratin may not be useful as a marker for distinguishing
normal vs. neoplastic epidermal tissues.
Reciprocal Expression of Molecular Markers for
Keratinization and Hyperproliferation
Terminal differentiation and cell replication are by defini-
tion two mutually exclusive cellular events, which maintain a
delicate balance. Consistent with this notion, the relative
expression of keratinization markers (the 56.5- and 65-67-kd
keratins) and hyperproliferation markers (the 48- and 56-kd
keratins) by keratinocytes varied in a roughly reciprocal fash-
ion depending on the growth and/or differentiated states of
the cells (Figs. 1 and 5). These results provide direct biochem-
ical evidence for the mutual exclusiveness of keratinization
(an "advanced" form of epidermal terminal differentiation;
[571) vs. hyperproliferation.
Keratins of Basal Cell Carcinoma
We have confirmed and extended the original observation
by Kubilus et al. (28) that the keratin pattern of BCC is very
similar to that ofcultured epidermal keratinocytes. Our results
are also in accordance with Moll et al., who demonstrated
that a 46-kd keratin (no. 17) is present in BCC but not in
normal epidermis (40; also see 28). However, since this keratin
is found not only in cells of the pilosebaceous unit, but also
in HeLa cells, cultured normal skin, corneal, conjunctival,
and esophageal keratinocytes, as well as in several epidermal
diseases including psoriasis (Fig. 4, lane 4; [10, 21, 39, 40, 61,
62, 741), this keratin is not cell-type-specific and its presence
in BCC should not be taken as evidence for a pilosebaceous
origin ofthe neoplasm.
48-kd Keratin Expression vs. Suprabasal
AEI-Staining Pattern of Epidermal Diseases
We have recently used AEI antibody to stain immunohis-
tochemically frozen sections of various epidermal diseases.
Although in normal epidermis this antibody selectively stains
basal cells (72), it produced a suprabasal staining pattern in
all benign epidermal diseases that are 48-kd-keratin positive
(70). Although these two events (AEI suprabasal staining
pattern and 48-kd-keratin expression) appear to be closely
related, additional experiments will be needed to show
whetherin hyperproliferative epidermis the 48-kdkeratin may
be expressed preferentially by suprabasal cells.
Concluding Remarks
When keratinocytes from psoriatic epidermis and basal cell
carcinoma are grown in culture, they behave similar to cul-
tured normal epidermal cells (2, 8, 28, 35; M. Jarvinen, S.
Passman, I. M. Freedberg, and T.-T. Sun, unpublished re-
sults). The reason for this becomes obvious if one assumes
that, in culture, the growth of keratinocytes may be stimulated
almost fully (position D in Fig. 5), thus obliterating the in
vivo differences between normal and diseased tissues.
During recent years, cultured keratinocytes have been used
extensively for studying various aspects of "normal" epider-
mal growth and differentiation. However, our results clearly
establishedthat as far as keratin expression is concerned, these
cells resemble hyperproliferative epidermal conditions and
thus may be useful, instead, as a model for studying epidermal
hyperplasia. Conversely, our findings also suggest that extrap-
olation of certain data obtained by using cultured keratino-
cytes to the normal in vivo situation should be done only
with great caution.
Although it is generally agreed that epidermal keratin
expression can be influenced by diseases, the question of
whether any such changes might be disease-specific and thus
of diagnostic value has not yet been settled. Consistent with
earlier results by Baden et al. (5), Steinert et al. (54), Hunter
and Skerrow (26), and Bowden et al. (8), we have not been
able to find any well-defined "disease-specific" keratins in the
common hyperproliferative disorders studied. Moreover, our
results suggest that there were extensive overlaps among ker-
atins ofvarious diseases (Fig. 1), and that a broad, continuous
spectrum of keratin expression can occureven within a given
disease (e.g., psoriasis; Fig. 4). These findings provide an
explanation for the controversy regarding the presence of the
high molecular weight keratins in psoriatic epidermis (1, 5, 8,
37, 50, 54, 66). Our results have also shown that, contrary to
some earlier suggestions (1, 71), keratin analysis may not be
helpful for the differential diagnosis of most epidermal dis-
eases, or for discriminating benign vs. malignant epithelial
lesions (however, for distinguishing carcinomas of simple vs.
stratifiedepithelial origins by keratin analysis, see 39, 41, 42).
Finally, the apparent lack of any major, disease-specific ker-
atin changes in the epidermal diseases studied so far implies
that keratin abnormalities probably represent the conse-
quence, rather than the cause, of these diseases.
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